ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 715135 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 715135; 2) Community: the network communities that were significantly associated with the response to NSC 715135; 3) Molecule: the relationships between components within communities and NSC 715135; 4) MDR: the compounds that were significantly associated with the NSC 715135.

NSC Compound Enrichment Correlation
NSC 736563 2-(4-chloro-2-methylphenoxy)-N-(4-chlorobenzo[d]thiazol-2-yl )acetamide 0.0135714101922724 0.073574171
NSC 745062 Null 0.0135714101922724 -0.31856673
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0135714101922724 -0.14451806
NSC 754081 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0135714101922724 -0.23420739
NSC 93739 Aizen Magenta 0.0135714101922724 0.3445237
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0135714101922725 -0.27927265
NSC 651081 1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-hydroxy-7-methyl- 0.0135714101922725 -0.020409335
NSC 726267 Null 0.0138010872611484 0.28119693
NSC 740 Methotrexate 0.0138010872611484 -0.3891092
NSC 753769 Null 0.0138010872611484 0.51818134
Total:57  Current:17    [First] [Prev] [Next] [Last]